Trials / Sponsors / NeoTX Therapeutics Ltd.
NeoTX Therapeutics Ltd.
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | NAP in Combination With Docetaxel Following Obinutuzumab Pretreatment in Subjects With Checkpoint Inhibitor Pr Non-small Cell Lung Cancer | Phase 2 | 2021-10-26 |
| Active Not Recruiting | Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid T ER+ Breast Cancer, Ovarian Cancer, Cervical Squamous Cell Carcinoma | Phase 1 | 2019-10-10 |